
HGH Fragment 176-191 Peptide Therapy
Benefits, Side Effects, Cost & Protocols
HGH Fragment 176-191 is a modified form of amino acids 176-191 of the human growth hormone polypeptide. It is specifically studied for its lipolytic (fat-burning) properties without the growth-promoting effects of full-length HGH, making it of interest for targeted fat loss.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Who Is HGH Fragment 176-191 Best For?
How HGH Fragment 176-191 Works
Isolated lipolytic region of HGH that may stimulate fat breakdown without affecting blood sugar or promoting cellular growth.
HGH Fragment 176-191 FAQ
What is HGH FRAGMENT 176-191?
HGH Fragment 176-191 is a modified fragment of human growth hormone containing the fat-burning portion without growth effects, making it a focused tool for fat metabolism research.
How does HGH FRAGMENT 176-191 work?
Isolated lipolytic region of HGH that may stimulate fat breakdown without affecting blood sugar or promoting cellular growth.
Is HGH FRAGMENT 176-191 legal to buy?
HGH FRAGMENT 176-191 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy HGH FRAGMENT 176-191?
HGH FRAGMENT 176-191 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.
What category does HGH FRAGMENT 176-191 belong to?
HGH FRAGMENT 176-191 is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.
What are the research benefits of HGH FRAGMENT 176-191?
HGH FRAGMENT 176-191 has been studied for: Fat metabolism, Lipolysis research, Body composition. Fat-specific GH fragment.
Key Studies
2 total on PubMed1 human trialsHuman Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells
Habibullah MM, Mohan S, Syed NK et al
In Vitro · Drug Des Devel Ther
HGH fragment 176-191 peptide increased doxorubicin-loaded chitosan nanoparticle toxicity against MCF-7 breast cancer cells
HGH Fragment 176-191 Compound Data
HGH Fragment 176-191 News
Amino acid composition drives aggregation during peptide synthesis - Nature
Nature · 1 month ago
AOD-9604 Peptide: Unlocking Its Potential in Metabolic and Regenerative Research - Health Tech World
Health Tech World · 12 months ago
The expanding research landscape of a Lipolytic Peptide - Pulse Kenya
Pulse Kenya · 12 days ago
Trainer advertised performance-enhancing drugs before working with Canelo Álvarez - The Guardian
The Guardian · 8 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore HGH Fragment 176-191 with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in HGH Fragment 176-191.
Take the Quiz →